Case number 2022-2133
United Therapeutics Corporation v. Liquidia Technologies, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 19, 2024 | 89 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [1025914] [MVH] [Entered: 08/19/2024 12:23 PM] (1) |
| Jun 30, 2024 | 0 | UNITED THERAPEUTICS CORPORATION v. LIQUIDIA TECHNOLOGIES, INC. [OPINION] [nonprecedential] (0) |
| Jun 27, 2024 | 88 | This entry was made in error and has been removed from the docket. [MVH] [Entered: 06/27/2024 09:29 AM] (0) |
| Jun 27, 2024 | 87 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [1013856] [MVH] [Entered: 06/27/2024 09:25 AM] (1) |
| Jun 27, 2024 | 86 | OPINION filed for the court by Hughes, Circuit Judge; Stoll, Circuit Judge and Cunningham, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [1013854] [MVH] [Entered: 06/27/2024 09:23 AM] (14) |
| Feb 6, 2024 | 85 | Submitted after ORAL ARGUMENT to Panel: Hughes, Circuit Judge; Stoll, Circuit Judge and Cunningham, Circuit Judge.Arguing counsel: William M. Jay for United Therapeutics Corporation, Sanya Sukduang for Liquidia Technologies, Inc. and Maureen Donovan Queler for Katherine K. Vidal.Oral Argument Audio available here. [981906] [MJL] [Entered: 02/06/2024 01:52 PM] (0) |
| Dec 29, 2023 | 84 | Response to notice of oral argument from Appellant United Therapeutics Corporation. Service: 12/29/2023 by email. [973673] [22-2133] [William Jay] [Entered: 12/29/2023 01:18 PM] (1) |
| Dec 21, 2023 | 83 | Response to notice of oral argument from Appellee Liquidia Technologies, Inc.. Service: 12/21/2023 by email. [972220] [22-2133] [Sanya Sukduang] [Entered: 12/21/2023 03:57 PM] (1) |
| Dec 21, 2023 | 82 | Response to notice of oral argument from Intervenor Katherine K. Vidal. Service: 12/21/2023 by email. [972203] [22-2133] [Maureen Queler] [Entered: 12/21/2023 03:42 PM] (1) |
| Dec 15, 2023 | 81 | NOTICE OF ORAL ARGUMENT. Panel: 2402B. Case scheduled February 6, 2024. Response to Notice of Oral Argument due: 12/29/2023. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [970685] [MJL] [Entered: 12/15/2023 02:09 PM] (2) |
| Nov 2, 2023 | 80 | The following conflict dates submitted by Sanya Sukduang for Liquidia Technologies, Inc. have been accepted by the court: 05/07/2024, 05/08/2024, 05/09/2024, 05/10/2024, 06/03/2024, 06/04/2024, 06/05/2024, 06/06/2024, 06/07/2024. [960858] [MJL] [Entered: 11/02/2023 09:18 AM] (0) |
| Nov 2, 2023 | 79 | The following conflict dates submitted by William M. Jay for United Therapeutics Corporation have been accepted by the court: 03/04/2024, 03/05/2024, 03/06/2024, 03/07/2024, 03/08/2024. [960856] [MJL] [Entered: 11/02/2023 09:17 AM] (0) |
| Nov 2, 2023 | 78 | The following conflict dates submitted by Maureen Donovan Queler for Katherine K. Vidal have been accepted by the court: 04/01/2024, 04/02/2024, 05/06/2024, 06/06/2024, 06/07/2024. [960852] [MJL] [Entered: 11/02/2023 09:14 AM] (0) |
| Nov 1, 2023 | 77 | Notice from Appellee Liquidia Technologies, Inc. regarding conflicts with oral argument. Service: 11/01/2023 by email. [960668] [22-2133] [Sanya Sukduang] [Entered: 11/01/2023 01:40 PM] (3) |
| Nov 1, 2023 | 76 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument. Service: 11/01/2023 by email. [960634] [22-2133] [William Jay] [Entered: 11/01/2023 11:57 AM] (3) |
| Nov 1, 2023 | 75 | Notice from Intervenor Katherine K. Vidal regarding conflicts with oral argument. Service: 11/01/2023 by email. [960619] [22-2133] [Maureen Queler] [Entered: 11/01/2023 11:19 AM] (3) |
| Oct 26, 2023 | 74 | Notice from Intervenor Katherine K. Vidal of Withdrawal of Director's Counsel (Thomas W. Krause). Service: 10/26/2023 by email. [959291] [22-2133] [Farheena Rasheed] [Entered: 10/26/2023 02:02 PM] (1) |
| Oct 25, 2023 | 73 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [958863] [ALK] [Entered: 10/25/2023 12:40 PM] (1) |
| Oct 16, 2023 | 72 | Clerk's Note to the File: The conflict dates requested by United Therapeutics Corporation (see Doc. No. [71]) are not accepted at this time. [956722] [MJL] [Entered: 10/16/2023 04:12 PM] (0) |
| Oct 16, 2023 | 71 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument. Service: 10/16/2023 by email. [956577] [22-2133] [William Jay] [Entered: 10/16/2023 01:59 PM] (3) |
| Sep 20, 2023 | 70 | Notice from Appellee Liquidia Technologies, Inc. regarding conflicts with oral argument. Service: 09/20/2023 by email. [951257] [22-2133] [Sanya Sukduang] [Entered: 09/20/2023 12:40 PM] (3) |
| Sep 15, 2023 | 69 | **TEXT ONLY** ORDER granting motion to withdraw attorney Deepa Kannappan [68] filed by Appellee Liquidia Technologies, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [950166] [ALK] [Entered: 09/15/2023 09:11 AM] (0) |
| Sep 14, 2023 | 67 | The following additional conflict dates submitted by William M. Jay for United Therapeutics Corporation have been accepted by the court: 12/06/2023, 12/07/2023. [949967] [MJL] [Entered: 09/14/2023 10:56 AM] (0) |
| Sep 14, 2023 | 66 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument. Service: 09/14/2023 by email. [949940] [22-2133] [William Jay] [Entered: 09/14/2023 10:10 AM] (3) |
| Sep 14, 2023 | 68 | MOTION of Appellee Liquidia Technologies, Inc. to withdraw counsel Deepa Kannappan. Service: 09/14/2023 by email. [950036] [22-2133] [Sanya Sukduang] [Entered: 09/14/2023 02:08 PM] (7) |
| Aug 22, 2023 | 65 | The following conflict dates submitted by Sanya Sukduang for Liquidia Technologies, Inc. have been accepted by the court: 12/04/2023, 12/05/2023. [944995] [MJL] [Entered: 08/22/2023 02:40 PM] (0) |
| Aug 18, 2023 | 64 | Notice from Appellee Liquidia Technologies, Inc. regarding conflicts with oral argument. Service: 08/18/2023 by email. [944343] [22-2133] [Sanya Sukduang] [Entered: 08/18/2023 04:07 PM] (3) |
| Jun 16, 2023 | 63 | The following additional conflict date submitted by William M. Jay for United Therapeutics Corporation has been accepted by the court: 08/11/2023. [930558] [MJL] [Entered: 06/16/2023 10:44 AM] (0) |
| Jun 15, 2023 | 62 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument. Service: 06/15/2023 by email. [930453] [22-2133] [William Jay] [Entered: 06/15/2023 05:10 PM] (3) |
| Apr 28, 2023 | 58 | The following conflict dates submitted by Deepa Kannappan for Liquidia Technologies, Inc. have been accepted by the court: 09/05/2023, 09/06/2023, 09/07/2023, 09/08/2023. [919749] [MJL] [Entered: 04/28/2023 10:12 AM] (0) |
| Apr 28, 2023 | 57 | The following conflict dates submitted by William M. Jay for United Therapeutics Corporation have been accepted by the court: 07/13/2023, 07/14/2023, 08/07/2023, 10/06/2023. [919747] [MJL] [Entered: 04/28/2023 10:10 AM] (0) |
| Apr 28, 2023 | 56 | The following conflict dates submitted by Maureen Donovan Queler for Katherine K. Vidal have been accepted by the court: 07/10/2023, 07/11/2023, 08/07/2023, 08/08/2023, 08/09/2023, 09/05/2023, 11/06/2023, 11/07/2023, 12/08/2023. [919746] [MJL] [Entered: 04/28/2023 10:09 AM] (0) |
| Apr 27, 2023 | 55 | Notice from Appellee Liquidia Technologies, Inc. regarding conflicts with oral argument. Service: 04/27/2023 by email. [919648] [22-2133] [Deepa Kannappan] [Entered: 04/27/2023 05:13 PM] (3) |
| Apr 27, 2023 | 54 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument. Service: 04/27/2023 by email. [919638] [22-2133] [William Jay] [Entered: 04/27/2023 04:53 PM] (3) |
| Apr 27, 2023 | 53 | Notice from Intervenor Katherine K. Vidal regarding conflicts with oral argument. Service: 04/27/2023 by email. [919505] [22-2133] [Maureen Queler] [Entered: 04/27/2023 10:39 AM] (3) |
| Apr 25, 2023 | 61 | 6 paper copies of Doc. No. [50], [47], [32] received from Appellant United Therapeutics Corporation. [920111] [VDW] [Entered: 05/01/2023 11:28 AM] (0) |
| Apr 24, 2023 | 60 | 6 paper copies of Doc. No. [36] received from Appellee Liquidia Technologies, Inc.. [920037] [VDW] [Entered: 05/01/2023 09:14 AM] (0) |
| Apr 24, 2023 | 59 | 6 paper copies of Doc. No. [38] received from Intervenor Katherine K. Vidal. [920036] [VDW] [Entered: 05/01/2023 09:08 AM] (0) |
| Apr 20, 2023 | 52 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [917864] [ALK] [Entered: 04/20/2023 09:29 AM] (0) |
| Apr 20, 2023 | 51 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [917863] [ALK] [Entered: 04/20/2023 09:27 AM] (1) |
| Apr 13, 2023 | 50 | MODIFIED ENTRY: APPENDIX FILED by Appellant United Therapeutics Corporation. Service: 04/13/2023 by email. [916620] --[Edited 04/20/2023 by ALK - compliance review complete] [Jaime Santos] [Entered: 04/13/2023 03:20 PM] (1273) |
| Apr 13, 2023 | 49 | NOTICE OF NON-COMPLIANCE: The submission of Appellant United Therapeutics Corporation, Appendix [48], is not in compliance with the rules of this court (see attached). Compliant document due on 04/20/2023. Service as of this date by the Clerk of Court. [916478] [ALK] [Entered: 04/13/2023 10:10 AM] (1) |
| Apr 10, 2023 | 48 | CORRECTED APPENDIX FILED by Appellant United Therapeutics Corporation. Service: 04/06/2023 by email. [915540] [22-2133] This document is non-compliant. See Doc No. [49]. [Jaime Santos] [Entered: 04/10/2023 10:37 AM] (1271) |
| Apr 7, 2023 | 45 | NOTICE OF NON-COMPLIANCE: The submission of Appellant United Therapeutics Corporation, Reply Brief [43], is not in compliance with the rules of this court (see attached). Compliant document due on 04/14/2023. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [915181]--[Edited 04/07/2023 by ALK to update docket text and notice.] [ALK] [Entered: 04/07/2023 08:58 AM] (1) |
| Apr 7, 2023 | 46 | Notice of Correction to Doc No. [43], [44] for Appellant United Therapeutics Corporation. Service: 04/07/2023 by email. [915469] [22-2133] [Jaime Santos] [Entered: 04/07/2023 05:43 PM] (3) |
| Apr 7, 2023 | 47 | MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED by Appellant United Therapeutics Corporation. Service: 04/07/2023 by email. [915470] --[Edited 04/13/2023 by ALK - compliance review complete] [Jaime Santos] [Entered: 04/07/2023 05:51 PM] (48) |
| Apr 6, 2023 | 44 | APPENDIX FILED by Appellant United Therapeutics Corporation. Service: 04/06/2023 by email. [915147] [22-2133]--[Edited 04/13/2023 by ALK. This document has been corrected. See ECF 46.] [Jaime Santos] [Entered: 04/06/2023 06:33 PM] (1271) |
| Mar 30, 2023 | 43 | REPLY BRIEF FILED by Appellant United Therapeutics Corporation. Service: 03/30/2023 by email. [913469] [22-2133] This document is non-compliant. See Doc No. [45]. [Jaime Santos] [Entered: 03/30/2023 08:16 PM] (47) |
| Mar 8, 2023 | 42 | ORDER granting the motions [39] [40] filed by Appellant United Therapeutics Corporation. Appeal No. 2022-2133 is no longer designated a companion to Appeal Nos. 2022-2217 and 2023-1021. UTC's reply brief in Appeal No. 2022-2133 is due no later than March 30, 2023. Service as of this date by the Clerk of Court. [908613] [22-2133, 22-2217] [LMS] [Entered: 03/08/2023 02:51 PM] (3) |
| Feb 28, 2023 | 41 | Entry of Appearance for Rohiniyurie Tashima as counsel for Appellant United Therapeutics Corporation. Service: 02/28/2023 by email. [906963] [22-2133] [Rohiniyurie Tashima] [Entered: 02/28/2023 04:50 PM] (1) |
| Feb 21, 2023 | 40 | MOTION of Appellant United Therapeutics Corporation to extend the time to 03/30/2023 to file brief. Service: 02/21/2023 by email. [905203] [22-2133] [Jaime Santos] [Entered: 02/21/2023 03:03 PM] (10) |
| Feb 21, 2023 | 39 | MOTION of Appellant United Therapeutics Corporation to De-Designate Companion Cases. Service: 02/21/2023 by email. [905200] [22-2133] [Jaime Santos] [Entered: 02/21/2023 03:00 PM] (9) |
| Feb 16, 2023 | 38 | MODIFIED ENTRY: INTERVENOR BRIEF FILED by Intervenor Katherine K. Vidal. Service: 02/16/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [904762] --[Edited 02/28/2023 by ALK - compliance review complete] [Maureen Queler] [Entered: 02/16/2023 05:17 PM] (29) |
| Jan 6, 2023 | 37 | **TEXT ONLY** ORDER granting motion to extend time to file brief [35] filed by Intervenor Katherine K. Vidal. The intervenor brief is due 02/16/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [895125] [ALK] [Entered: 01/06/2023 10:36 AM] (0) |
| Jan 6, 2023 | 36 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Liquidia Technologies, Inc. Service: 01/06/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [895075] --[Edited 01/10/2023 by ALK - compliance review complete] [Sanya Sukduang] [Entered: 01/06/2023 09:14 AM] (73) |
| Jan 5, 2023 | 35 | MOTION of Intervenor Katherine K. Vidal to extend the time to 02/16/2023 to file brief. Service: 01/05/2023 by email. [894886] [22-2133] [Maureen Queler] [Entered: 01/05/2023 01:29 PM] (5) |
| Dec 20, 2022 | 34 | Docketing Statement for the Intervenor Katherine K. Vidal. Service: 12/20/2022 by email. [891716] [22-2133] [Maureen Queler] [Entered: 12/20/2022 09:35 AM] (2) |
| Dec 6, 2022 | 33 | ORDER filed granting the motion. The revised official caption is reflected above. Intervenor is directed to file a docketing statement no later than 14 days from the date of filing of this order. Intervenor's brief is due within 40 days of the date of filing of this order. Appellant's reply brief is due no later than 21 days from the date of filing of intervenor's brief. Service as of this date by the Clerk of Court. [888793] [LMS] [Entered: 12/06/2022 04:05 PM] (2) |
| Nov 28, 2022 | 32 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant United Therapeutics Corporation. Service: 11/28/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [886829] --[Edited 12/02/2022 by ALK - compliance review complete] [Jaime Santos] [Entered: 11/28/2022 09:43 PM] (148) |
| Nov 28, 2022 | 31 | Amended Certificate of Interest for Appellant United Therapeutics Corporation. Service: 11/28/2022 by email. [886828] [22-2133] [Jaime Santos] [Entered: 11/28/2022 09:29 PM] (3) |
| Nov 21, 2022 | 30 | Entry of appearance for Maureen D. Queler; Thomas W. Krause; Farheena Y. Rasheed; Mary L. Kelly as counsel for Director of the United States Patent and Trademark Office. Service: 11/21/2022 by email. [885563] [22-2133] [Maureen Queler] [Entered: 11/21/2022 02:55 PM] (2) |
| Nov 21, 2022 | 29 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 11/21/2022 by email. [885560] [22-2133] [Maureen Queler] [Entered: 11/21/2022 02:52 PM] (2) |
| Nov 20, 2022 | 0 | UNITED THERAPEUTICS CORPORATION v. LIQUIDIA TECHNOLOGIES, INC. [ORDER] [nonprecedential] (0) |
| Nov 18, 2022 | 28 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [27] filed by Cross-Appellant Liquidia Technologies, Inc. in 22-2133; Appeal No. 22-2174 is dismissed; Each party shall bear its own costs with respect to Appeal No. 22-2174; Appeal No. 22-2174 is deconsolidated from 22-2133, and the revised official caption is reflected in the order; issuing mandate in 22-2174 only. Service as of this date by the Clerk of Court. [885200] [22-2133, 22-2174] [ALK] [Entered: 11/18/2022 04:39 PM] (2) |
| Nov 14, 2022 | 27 | MOTION of Cross-Appellant Liquidia Technologies, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 11/14/2022 by email. [883662] [22-2133] [Sanya Sukduang] [Entered: 11/14/2022 10:05 AM] (5) |
| Oct 12, 2022 | 26 | ORDER filed denying the motions [20] [874263-2] filed by Liquidia Technologies, Inc. Service as of this date by the Clerk of Court. [877254] [22-2133, 22-2217] [LMS] [Entered: 10/12/2022 01:21 PM] (2) |
| Oct 6, 2022 | 25 | REPLY of Cross-Appellant Liquidia Technologies, Inc. to response [24]. Service: 10/06/2022 by email. [876419] [22-2133] [Sanya Sukduang] [Entered: 10/06/2022 03:40 PM] (322) |
| Oct 4, 2022 | 23 | Entry of appearance for Arthur P. Dykhuis as counsel for Appellant United Therapeutics Corporation. Service: 10/04/2022 by email. [875733] [22-2133] [Arthur Dykhuis] [Entered: 10/04/2022 01:01 PM] (1) |
| Oct 4, 2022 | 24 | RESPONSE of Appellant United Therapeutics Corporation to Doc No. [20], [20]. Service: 10/04/2022 by email. [875935] [22-2133] [Jaime Santos] [Entered: 10/04/2022 07:57 PM] (19) |
| Oct 3, 2022 | 22 | Certified list received. Service: 09/27/2022 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [875472] [22-2133, 22-2174] [ALK] [Entered: 10/03/2022 04:42 PM] (84) |
| Sep 29, 2022 | 21 | ORDER directing United Therapeutics to respond to the motions [20] [874263-2] no later than October 4, 2022. Any reply in support of the motions is due no later than three days thereafter. Service as of this date by the Clerk of Court. [874736] [22-2133, 22-2217] [LMS] [Entered: 09/29/2022 12:52 PM] (2) |
| Sep 27, 2022 | 20 | MOTION of Cross-Appellant Liquidia Technologies, Inc. to expedite briefing schedule, to expedite.. Service: 09/27/2022 by email. [874257] [22-2133] [Sanya Sukduang] [Entered: 09/27/2022 04:16 PM] (254) |
| Sep 27, 2022 | 19 | Amended Certificate of Interest for Cross-Appellant Liquidia Technologies, Inc.. Service: 09/27/2022 by email. [874246] [22-2133] [Sanya Sukduang] [Entered: 09/27/2022 04:05 PM] (3) |
| Sep 19, 2022 | 18 | Note to File: The following cases shall be considered companion cases and assigned to the same merits panel: 22-2133 and 22-2217. [872439] [22-2133, 22-2217] [MMA] [Entered: 09/19/2022 09:22 AM] (0) |
| Sep 12, 2022 | 17 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [16], ERROR: Appellant's Entry of Appearance includes an incomplete case number. CORRECTION: Please include all consolidated case numbers on future filings. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [871168] [ALK] [Entered: 09/12/2022 12:50 PM] (0) |
| Sep 9, 2022 | 16 | Entry of appearance for Douglas H. Carsten; Adam Burrowbridge as counsel for Appellant United Therapeutics Corporation. Service: 09/09/2022 by email. [870976] [22-2133] [Douglas Carsten] [Entered: 09/09/2022 04:10 PM] (0) |
| Sep 9, 2022 | 15 | Corrected Entry of appearance for Sanya Sukduang; Jonathan R. Davies; Deepa Kannappan as counsel for Cross-Appellant Liquidia Technologies, Inc.. Service: 09/09/2022 by email. [870879] [22-2133] [Sanya Sukduang] [Entered: 09/09/2022 11:49 AM] (0) |
| Sep 9, 2022 | 14 | Amended Certificate of Interest for Cross-Appellant Liquidia Technologies, Inc.. Service: 09/09/2022 by email. [870878] [22-2133] [Sanya Sukduang] [Entered: 09/09/2022 11:46 AM] (0) |
| Sep 2, 2022 | 13 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [9], Doc No. [10], ERROR: Cross-appellant's Docketing Statement and Certificate of Interest include an incomplete case number. CORRECTION: Please include all consolidated case numbers on future filings. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [869781] [ALK] [Entered: 09/02/2022 03:04 PM] (0) |
| Sep 2, 2022 | 12 | NOTICE OF NON-COMPLIANCE: The submission of Cross-Appellant Liquidia Technologies, Inc., Entry of Appearance [8], is not in compliance with the rules of this court (see attached). Compliant document due on 09/12/2022. Service as of this date by the Clerk of Court. [869779] [ALK] [Entered: 09/02/2022 02:56 PM] (0) |
| Sep 2, 2022 | 11 | Corrected Entry of appearance for Jaime A. Santos, William M. Jay, Jenny J. Zhang, William Covington Jackson, Shaun R. Snader as counsel for Appellant United Therapeutics Corporation. Service: 09/02/2022 by email. [869702] [22-2133] [Jaime Santos] [Entered: 09/02/2022 11:57 AM] (0) |
| Sep 1, 2022 | 6 | Note to File: The following cases are associated: 22-2133 (Lead) with 22-2174 (Cross-Appeal). The parties must file all documents in the lead appeal only. [869410] [22-2133, 22-2174] [ALK] [Entered: 09/01/2022 09:38 AM] (0) |
| Sep 1, 2022 | 10 | Certificate of Interest for Cross-Appellant Liquidia Technologies, Inc.. Service: 09/01/2022 by email. [869577] [22-2133] [Sanya Sukduang] [Entered: 09/01/2022 04:47 PM] (0) |
| Sep 1, 2022 | 9 | Docketing Statement for the Cross-Appellant Liquidia Technologies, Inc.. Service: 09/01/2022 by email. [869575] [22-2133] [Sanya Sukduang] [Entered: 09/01/2022 04:45 PM] (0) |
| Sep 1, 2022 | 8 | Entry of appearance for Sanya Sukduang; Jonathan Davies; Deepa Kannapan as counsel for Cross-Appellant Liquidia Technologies, Inc.. Service: 09/01/2022 by email. [869573] [22-2133] This document is non-compliant. See Doc No. [12]. [Sanya Sukduang] [Entered: 09/01/2022 04:42 PM] (0) |
| Sep 1, 2022 | 7 | Official caption revised to reflect cross-appeal with 22-2174. (see attached). Service as of this date by the Clerk of Court. [869412] [ALK] [Entered: 09/01/2022 09:39 AM] (0) |
| Aug 31, 2022 | 5 | NOTICE OF NON-COMPLIANCE: The submission of Appellant United Therapeutics Corporation, Entry of Appearance [2], is not in compliance with the rules of this court (see attached). Compliant document due on 09/08/2022. Service as of this date by the Clerk of Court. [869121] [ALK] [Entered: 08/31/2022 08:49 AM] (1) |
| Aug 30, 2022 | 4 | Certificate of Interest for Appellant United Therapeutics Corporation. Service: 08/30/2022 by email. [869039] [22-2133] [Jaime Santos] [Entered: 08/30/2022 04:34 PM] (3) |
| Aug 30, 2022 | 3 | Docketing Statement for the Appellant United Therapeutics Corporation. Service: 08/30/2022 by email. [869037] [22-2133] [Jaime Santos] [Entered: 08/30/2022 04:33 PM] (2) |
| Aug 30, 2022 | 2 | Entry of appearance for Jaime A. Santos; William M. Jay; Jenny J. Zhang; William Covington Jackson; Shaun R. Snader as counsel for Appellant United Therapeutics Corporation. Service: 08/30/2022 by email. [869033] [22-2133] This document is non-compliant. See Doc No. [5]. [Jaime Santos] [Entered: 08/30/2022 04:31 PM] (2) |
| Aug 18, 2022 | 1 | Appeal docketed. Received: 08/15/2022. [867249] Entry of Appearance is due on 09/01/2022. Certificate of Interest is due on 09/01/2022. Docketing Statement is due on 09/01/2022. Certified List is due on 09/27/2022. [ALK] [Entered: 08/18/2022 04:00 PM] (74) |
